Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tboothby
    Member
    • May 2011
    • 56

    #1

    RSEM expected counts question

    I want to check that I understand the output of RSEM correctly. As I understand it the "expected_count" output for each gene is the number of fragment reads that are predicted to map to that "gene."

    Read fragments that map to multiple "genes" are not thrown away but their mapping is divided among those "genes." Thus, you would expect most expected_count estimations to be non-integers.

    So if a particular "genes" expected_count value was 1215.54 that would mean that RSEM estimates 1215.54 reads mapped to it. Is this correct?

    Another question:
    Is there any benchmark for what a "good" expected_count would be in terms of assessing whether or not that gene is expressed?

    Does this mean that a transcript with an expected_count of say 8 only had 8 fragments map to it? If this is the case it probably isn't expressed, expressed at exceedingly low levels, or the sequencing was data is bad... right?

    Thanks for your input.
  • arvid
    Senior Member
    • Jul 2011
    • 156

    #2
    Originally posted by tboothby View Post
    So if a particular "genes" expected_count value was 1215.54 that would mean that RSEM estimates 1215.54 reads mapped to it. Is this correct?
    Yes.

    Originally posted by tboothby View Post
    Is there any benchmark for what a "good" expected_count would be in terms of assessing whether or not that gene is expressed?

    Does this mean that a transcript with an expected_count of say 8 only had 8 fragments map to it? If this is the case it probably isn't expressed, expressed at exceedingly low levels, or the sequencing was data is bad... right?
    There is no way of specifying an absolute threshold for a call expressed/not expressed, since this depends on the amount you sampled and the depth of sequencing... Thus it is virtually impossible to tell whether your gene is lowly expressed or not at all - it is simply below or at your detection threshold.

    Do replicates, then you can tell whether a weak measurement is robust.

    Comment

    • tboothby
      Member
      • May 2011
      • 56

      #3
      Another few questions:
      I have used Bowtie to map read fragments to a reference transcriptome. When I look at a sample of individual transcripts in IGV I see they have thousand fold coverage.

      When I look at the same transcripts in my RSEM output their "expected_count" numbers are low (at least thats my initial impression), with values of 15 or so.

      I am trying to understand why this is happening, are those thousands of fragments I see in IGV also mapping to other transcripts?

      Is there an easy way to check this?

      Would this cause such low expected_count values?

      Any other ideas of why this would be happening?

      Thanks for your input.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...